AGLAIA

Welcome to the Brand page for “AGLAIA”, which is offered here for Dna chips for medical diagnosis; computer software for genetic analysis for medical purposes; computer software for use in medical testing and diagnosis, computer software for detecting single-nucleotide polymorphisms, somatic mutations and specific sequences for medical diagnosis;reagents for medical and clinical diagnosis purposes; medicines for in-vitro diagnosis; reagents for medical and veterinary genetic testing; medical diagnostic reagents comprised of genetic chips for clinical diagnosis; reagents for medical treatment purposes, for detecting gene polymorphisms; reagents for medical treatment purposes, for dna extraction; reagents for medical treatment purposes, for dna amplification; reagents for medical treatment purposes, for selecting best course medical treatment including identifying infectious agents, vulnerability against specific disease, and selecting most effective and least adverse effect medicine; reagents for gene analysis for medical treatment purposes, for selecting best course medical treatment including identifying infectious agents, vulnerability against specific disease, and selecting most effective and least adverse effect medicine;color is not claimed as a feature of the mark.;in vitro analysis apparatus and instruments primarily for detecting single-nucleotide polymorphisms, somatic mutations and specific sequences; medical diagnostic apparatus for determining appropriate medical treatment based on genetic analysis of patient morbidity and physical condition; clinical chemical analysis devices comprising automatic dispensers, dna extracting units, fluorescent detecting units and thermostats; medical diagnostic apparatus comprised primarily of dna chips and dna extracting cartridges for genetic analysis of patients; medical diagnostic apparatus for the genetic analysis of single-nucleotide polymorphisms, somatic mutations, nucleic acids, proteins, chemical compounds, oligonucleotides, and polypeptides samples; medical diagnostic apparatus for the genetic analysis of biological matter extracted from humans and animals;.

Its status is currently believed to be active. Its class is unavailable. “AGLAIA” is believed to be currently owned by “TOPPAN PRINTING CO., LTD.”